tm logo
Trademark Search
ORPHALAN INNOVATION FOR ORPHAN DISEASES
ORPHALAN INNOVATION FOR ORPHAN DISEASES
ADVERTISED

on 09 Oct 2024

Last Applicant/ Owned by

ORPHALAN

226 boulevard VoltaireF-75011 Paris

FR

Serial Number

2059235 filed on 09th Sep 2020

Correspondent Address

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

ORPHALAN INNOVATION FOR ORPHAN DISEASES

Vienna Information


1 . 15 . 15

DropsGouttes

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 7 . 5

Circles or ellipses with one or more other quadrilateralsCercles ou ellipses avec un ou plusieurs quadrilatères

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 7

Vertical lines or bandsLignes ou bandes verticales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

29 . 1 . 4

BlueBleu

29 . 1 . 5

VioletViolet

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Trademark usage description

acids for pharmaceutical use in the field of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmu Read More

Classification Information


Class [005]
Acids for pharmaceutical use in the field of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; diagnostic agents for pharmaceutical use in the field of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; capsules for pharmaceutical use in the field of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; pharmaceutical compounds for the screening and the treatment of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; drugs for the treatment of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; pharmaceutical products for the treatment of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; chemical preparations for pharmaceutical use in the field of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; chemical preparations for medical use in the field of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; medicines for the treatment of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis; medical products, namely medicines and drugs for the screening and the treatment of rare and orphan diseases, namely wilson disease, inherited disorders of the immune system namely autoimmune diseases, immunologic deficiency syndromes, inherited metabolic disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, inherited blood disorders namely bleeding disorders namely hemophilia, blood clots and blood cancers namely leukemia, lym-phoma and myeloma, inherited neuro-degenerative disorders namely alzheimer's disease, parkinson's disease, huntington's disease and multiple sclerosis


Classification kind code

11

Class [010]
Medical apparatus and instruments for the detection and the treatment of rare and orphan diseases namely X-ray apparatus for medical use, medical ultrasound apparatus, phototherapeutic apparatus for medical purposes; diagnostic apparatus for medical use namely apparatus for medical diagnostic testing in the field of rare and orphan diseases; testing apparatus for medical use namely apparatus for taking blood samples, urine and tissue specimens in the field of rare and orphan diseases; medical testing instruments namely medical instruments for general examination in the field of rare and orphan diseases; substance analysis apparatus for medical use namely automatic testing apparatus for measuring substance namely hormones, drugs, proteins and nucleic acids in blood and saliva in the field of rare and orphan diseases; instruments for extraction of liquids from the human body namely venom extraction syringes, blood drawing apparatus, medical fluid connectors in the field of rare and orphan diseases; blood testing apparatus namely apparatus for taking blood samples for the detection and the treatment of rare and orphan diseases; radiology apparatus namely medical ultrasound apparatus for the detection and the treatment of rare and orphan diseases; blood testing instruments for the detection and the treatment of rare and orphan diseases, namely apparatus for taking blood samples; gloves for medical use; gloves for veterinary use; syringes for medical use; injectors for medical use; X-rays for medical use; inhalers for medical purposes sold empty; radiology screens for medical use; receptacles for applying medicines, namely medical specimen cups, spoons for administering medicine, cups for administering medicine; containers especially made for medical waste; surgical probes; thermometers for medical use; cases fitted for medical instruments; stethoscopes; heart pacemakers; diagnostic imaging apparatus namely magnetic resonance imaging (mri) diagnostic apparatus for the detection and the treatment of rare and orphan diseases; needles for medical use.


Classification kind code

11

Class [042]
Development of pharmaceutical preparations and medicines; development of pharmaceutical products; clinical studies for pharmaceutical products; evaluation of pharmaceutical products; scientific research in the field of pharmacy; research regarding pharmaceutical products; pharmaceutical research and development; research relating to pharmaceutical products; research and development for the pharmaceutical industry in the field of rare and orphan diseases; conducting clinical trials for pharmaceutical products; drug development services; laboratory research services relating to pharmaceutical products; pharmaceutical research services; medical and pharmacological research services; pharmaceutical research and development services; scientific research for medical purposes; scientific laboratory services in the field of rare and orphan diseases; research and development in the field of biotechnology; design and development of medical diagnostic apparatus for the detection and the treatment of rare and orphan diseases.


Classification kind code

11

Class [044]
Advice relating to pharmacy in the field of rare and orphan diseases; advisory services relating to health namely medical counselling in the field of rare and orphan diseases; pharmaceutical advice; advice relating to medicines; medical information to patients on administering medicines for the screening and the treatment of rare and orphan diseases; medical information in the field of rare and orphan diseases; drug testing service for medical use; pharmaceutical services, namely medical care and analysis services relating to patient treatment in the field of rare and orphan diseases; medical services in the field of rare and orphan diseases; medical diagnostic services [testing and analysis]; advisory services relating to medical apparatus and instruments used in the field of rare and orphan diseases; diagnosis of diseases.


Classification kind code

11

Mark Details


Serial Number

2059235

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 15th Feb 2022
Search Recorded
Submitted for opposition 20
on 15th Feb 2022
Examiner's First Report
Submitted for opposition 223
on 15th Feb 2022
Total Provisional Refusal
Submitted for opposition 256
on 23rd Aug 2021
Notification of Possible Opposition Sent
Submitted for opposition 135
on 07th Apr 2021
Amendment to Application
Submitted for opposition 257
on 22nd Oct 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 21st Oct 2020
Formalized
Submitted for opposition 1
on 21st Oct 2020
Created
Submitted for opposition 228
on 09th Sep 2020
International Registration
Submitted for opposition 30
on 09th Sep 2020
Filed